Literature DB >> 10225590

Clinical course of patients with serologic evidence of recurrent genital herpes presenting with signs and symptoms of first episode disease.

C Diamond1, S Selke, R Ashley, J Benedetti, L Corey.   

Abstract

BACKGROUND AND OBJECTIVES: The care of patients with first episode and recurrent genital herpes differs with respect to therapy and source partner evaluation. Of 498 persons who presented with what appeared by history and symptoms to be a first episode of genital herpes, we identified 41 who had serologic evidence of remotely acquired herpes simplex virus 2 (HSV-2) infection. GOALS: To define the natural history of these individuals with previously unrecognized HSV-2 and to evaluate if any clinical or historical features could differentiate these people from persons with true first episode infection. STUDY
DESIGN: Observational cohort study.
RESULTS: Clinical overlap existed in the frequency of local symptoms, fever, and size of genital lesions between those with remotely acquired versus recently acquired genital herpes. The frequency of new sexual partners and recent sexual history were also similar in the two groups. However, on follow-up, the lesions of persons with remotely acquired HSV-2 healed more rapidly and subsequently recurred less frequently than those of true primary HSV-2.
CONCLUSIONS: Even in a referral clinic with experienced clinicians, almost 10% of persons who are judged to have first episode genital herpes have evidence of remotely acquired HSV-2, suggesting that clinical differentiation of first episode genital herpes from previously acquired infection is difficult. Type-specific serologic testing assists the clinician in correctly classifying the infection and determining the potential source partner.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225590     DOI: 10.1097/00007435-199904000-00007

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  12 in total

Review 1.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  Cohort studies in sexual health.

Authors:  C A Sabin; A N Phillips
Journal:  Sex Transm Infect       Date:  2001-06       Impact factor: 3.519

3.  Persistent genital herpes simplex virus-2 shedding years following the first clinical episode.

Authors:  Warren Phipps; Misty Saracino; Amalia Magaret; Stacy Selke; Mike Remington; Meei-Li Huang; Terri Warren; Corey Casper; Lawrence Corey; Anna Wald
Journal:  J Infect Dis       Date:  2010-12-09       Impact factor: 5.226

4.  Herpes simplex virus 2 infection rate and necessity of screening during pregnancy: a clinical and seroepidemiologic study.

Authors:  Il Dong Kim; Ho Sun Chang; Kyung Jin Hwang
Journal:  Yonsei Med J       Date:  2012-03       Impact factor: 2.759

Review 5.  Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision.

Authors:  A Scoular
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

6.  The epidemiology of genital infection with herpes simplex virus types 1 and 2 in genitourinary medicine attendees in inner London.

Authors:  M Ramaswamy; C McDonald; C Sabin; M Tenant-Flowers; M Smith; A M Geretti
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

7.  Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2.

Authors:  D N Fisman; E W Hook; S J Goldie
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

8.  Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.

Authors:  David W Kimberlin; Jill Baley
Journal:  Pediatrics       Date:  2013-01-28       Impact factor: 7.124

9.  The potential epidemiological impact of a genital herpes vaccine for women.

Authors:  G P Garnett; G Dubin; M Slaoui; T Darcis
Journal:  Sex Transm Infect       Date:  2004-02       Impact factor: 3.519

10.  Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women.

Authors:  David I Bernstein; Abbie R Bellamy; Edward W Hook; Myron J Levin; Anna Wald; Marian G Ewell; Peter A Wolff; Carolyn D Deal; Thomas C Heineman; Gary Dubin; Robert B Belshe
Journal:  Clin Infect Dis       Date:  2012-10-19       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.